期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 192, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112177
关键词
Diarylpentanoids; Chemotherapy; Curcumin; C5-curcuminoids; Antitumor activity; Structure-activity relationship
资金
- FCT Foundation for Science and Technology [UIDB/04423/2020, UIDP/04423/2020, UID/QUI/50006/2019, PTDC/SAUPUB/28736/2017, POCI-01-0145-FEDER-028736]
- [SFRH/BD/135852/2018]
- Fundação para a Ciência e a Tecnologia [SFRH/BD/135852/2018] Funding Source: FCT
Diarypentanoids are commonly considered as monocarbonyl analogues of curcumin. Since the discovery of this compound in 1962, twenty one diarylpentanoids have been isolated and almost 600 synthetic analogues with antitumor activity have been synthesized. This review reports the exploitation of diarylpentanoids to develop curcumin analogues with improved antitumor activity over the last two decades. The mechanism of action and structure-activity relationship (SAR) studies are also highlighted. More importantly, structural features for the antitumor activity that may guide the design of new and more effective diarylpentanoids are also proposed. (c) 2020 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据